Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Follicle-stimulating hormone (FSH) is a glycoprotein hormone produced by the anterior pituitary gland. It plays a central role in human reproduction and sexual development. In females, FSH stimulates the growth and maturation of ovarian follicles, which are necessary for ovulation and estrogen production. In males, it acts on Sertoli cells in the testes to promote spermatogenesis. The secretion of FSH is regulated by gonadotropin-releasing hormone (GnRH) from the hypothalamus as part of the hypothalamic-pituitary-gonadal axis[1][3][8]. Therapeutically, exogenous forms of FSH—either recombinant or purified from urine—are used to treat infertility by inducing ovulation in women undergoing assisted reproductive technologies such as IVF or IUI[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on follicle-stimulating hormone.